Ronald J Prentki - Net Worth and Insider Trading
Ronald J Prentki Net Worth
The estimated net worth of Ronald J Prentki is at least $137,670 dollars as of 2024-04-27. Ronald J Prentki is the President of Progenics Pharmaceuticals Inc and owns about 33,578 shares of Progenics Pharmaceuticals Inc (PGNX) stock worth over $137,670. Details can be seen in Ronald J Prentki's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Ronald J Prentki has not made any transactions after 2005-02-07 and currently still holds the listed stock(s).
Transaction Summary of Ronald J Prentki
Ronald J Prentki Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ronald J Prentki owns 2 companies in total, including Heron Therapeutics Inc (HRTX) , and Progenics Pharmaceuticals Inc (PGNX) .
Click here to see the complete history of Ronald J Prentki’s form 4 insider trades.
Insider Ownership Summary of Ronald J Prentki
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HRTX | Heron Therapeutics Inc | 2009-07-08 | director & President & CEO |
| PGNX | Progenics Pharmaceuticals Inc | 2005-02-07 | director & President |
Ronald J Prentki Latest Holdings Summary
Ronald J Prentki currently owns a total of 1 stock. Ronald J Prentki owns 33,578 shares of Progenics Pharmaceuticals Inc (PGNX) as of February 7, 2005, with a value of $137,670.
Latest Holdings of Ronald J Prentki
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PGNX | Progenics Pharmaceuticals Inc | 2005-02-07 | 33,578 | 4.10 | 137,670 |
Holding Weightings of Ronald J Prentki
Ronald J Prentki Form 4 Trading Tracker
According to the SEC Form 4 filings, Ronald J Prentki has made a total of 0 transactions in Progenics Pharmaceuticals Inc (PGNX) over the past 5 years. The most-recent trade in Progenics Pharmaceuticals Inc is the sale of 26,000 shares on February 7, 2005, which brought Ronald J Prentki around $548,340.
Insider Trading History of Ronald J Prentki
- 1
Ronald J Prentki Trading Performance
Ronald J Prentki Ownership Network
Ownership Network List of Ronald J Prentki
Ownership Network Relation of Ronald J Prentki
Ronald J Prentki Owned Company Details
What does Heron Therapeutics Inc do?
Who are the key executives at Heron Therapeutics Inc?
Ronald J Prentki is the director & President & CEO of Heron Therapeutics Inc. Other key executives at Heron Therapeutics Inc include EVP & Chief Development Officer William P Forbes , other: See Footnote 2 Adam Morgan , and EVP & Chief Financial Officer Ira Duarte .
Heron Therapeutics Inc (HRTX) Insider Trades Summary
Over the past 18 months, Ronald J Prentki made no insider transaction in Heron Therapeutics Inc (HRTX). Other recent insider transactions involving Heron Therapeutics Inc (HRTX) include a net purchase of 2,486,744 shares made by Adam Morgan , and a net purchase of 50,000 shares made by William P Forbes .
In summary, during the past 3 months, insiders sold 0 shares of Heron Therapeutics Inc (HRTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Heron Therapeutics Inc (HRTX) were sold and 2,536,744 shares were bought by its insiders, resulting in a net purchase of 2,536,744 shares.
Heron Therapeutics Inc (HRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Heron Therapeutics Inc Insider Transactions
Ronald J Prentki Mailing Address
Above is the net worth, insider trading, and ownership report for Ronald J Prentki. You might contact Ronald J Prentki via mailing address: 4 Charter Oak Lane, Greenwich Ct 06830.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
